Chemo besser als TKI bei EGFR-Wildtyp-NSCLC
Crossref DOI link: https://doi.org/10.1007/s15015-014-1267-y
Published Online: 2014-09-13
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bublak, Robert
Text and Data Mining valid from 2014-09-01